Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Apo Benztropine
2. Apo-benztropine
3. Bensylate
4. Benzatropine
5. Benzatropine Mesylate
6. Benzatropine Methanesulfonate
7. Benzatropine Methanesulfonate, Hydrobromide
8. Benzatropine Methanesulfonate, Hydrobromide, (endo)-isomer
9. Benzatropine Methanesulfonate, Hydrochloride, (endo)-isomer
10. Benztropine
11. Benztropine Mesylate
12. Cogentin
13. Cogentinol
14. Hydrobromide Benzatropine Methanesulfonate
15. Mesylate, Benzatropine
16. Mesylate, Benztropine
17. Methanesulfonate, Benzatropine
18. Methanesulfonate, Hydrobromide Benzatropine
19. N Methylbenztropine
20. N-methylbenztropine
21. Pms Benztropine
22. Pms-benztropine
1. Benztropine Mesylate
2. 132-17-2
3. Cogentin Mesylate
4. Benztropine (mesylate)
5. Mls000737056
6. Nsc42199
7. Benzotropine Mesylate
8. 3-(benzhydryloxy)-8-methyl-8-azabicyclo[3.2.1]octane Methanesulfonate
9. Smr000394012
10. Cobrentin Methanesulfonate
11. 3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic Acid
12. Mk 02
13. Benzatropine Mesylate;benzotropine Mesylate;benztropine Methanesulfonate
14. Tropine Benzohydryl Ether Methanesulfonate
15. 102701-02-0
16. Cogentin Methanesulfonate
17. Sr-01000075303
18. Benzotropine Methanesulfonate
19. Nsc-42199
20. Benzotropinemesylate
21. Opera_id_1229
22. Schembl41809
23. Chembl85236
24. Hy-b0520a
25. Hms2747a15
26. Hms3259p11
27. Hms3260h09
28. Hms3652k07
29. Tox21_500194
30. Nsc169913
31. 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane, Methanesulfonic Acid
32. Akos008105137
33. Ccg-221498
34. Lp00194
35. Nc00646
36. Sb19689
37. Ncgc00016118-02
38. Ncgc00093670-01
39. Ncgc00260879-01
40. As-17846
41. B5592
42. Cs-0300867
43. Eu-0100194
44. En300-51031
45. B 8262
46. Wln: T56 A Antj A1 Goyr & R & Osw1
47. Benzophenone-3,3'-4,4'-tetracarboxylic Dianhydrie
48. Q-200693
49. Sr-01000075303-1
50. Sr-01000075303-5
51. 8-azabicyclo[3.2.1]octane, Endo-, Methanesulfonate
52. 1.alpha.h, 3.alpha.-(diphenylmethoxy)-, Methanesulfonate
53. 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane,methanesulfonicacid
54. Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl Ether Methanesulfonate
Molecular Weight | 403.5 g/mol |
---|---|
Molecular Formula | C22H29NO4S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 403.18172958 g/mol |
Monoisotopic Mass | 403.18172958 g/mol |
Topological Polar Surface Area | 75.2 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 433 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Benztropine mesylate |
PubMed Health | Benztropine Mesylate (By mouth) |
Drug Classes | Antiparkinsonian |
Drug Label | Benztropine Mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine.It is a crystalline white powder, very soluble in water, designated as 3-(Diphenylmethoxy)-1H, 5H-tropane methanesulfonate, with t... |
Active Ingredient | Benztropine mesylate |
Dosage Form | Injectable; Tablet |
Route | Injection; Oral |
Strength | 1mg/ml; 0.5mg; 2mg; 1mg |
Market Status | Prescription |
Company | Corepharma; Navinta; Fresenius Kabi Usa; Excellium; Vintage; Usl Pharma; Luitpold; Hikma Farmaceutica; Pliva; Invagen Pharms |
2 of 2 | |
---|---|
Drug Name | Benztropine mesylate |
PubMed Health | Benztropine Mesylate (By mouth) |
Drug Classes | Antiparkinsonian |
Drug Label | Benztropine Mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine.It is a crystalline white powder, very soluble in water, designated as 3-(Diphenylmethoxy)-1H, 5H-tropane methanesulfonate, with t... |
Active Ingredient | Benztropine mesylate |
Dosage Form | Injectable; Tablet |
Route | Injection; Oral |
Strength | 1mg/ml; 0.5mg; 2mg; 1mg |
Market Status | Prescription |
Company | Corepharma; Navinta; Fresenius Kabi Usa; Excellium; Vintage; Usl Pharma; Luitpold; Hikma Farmaceutica; Pliva; Invagen Pharms |
Dopamine Uptake Inhibitors
Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-10-25
Pay. Date : 2012-12-19
DMF Number : 6914
Submission : 1987-04-09
Status : Active
Type : II
NDC Package Code : 48954-448
Start Marketing Date : 1987-04-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-04-02
Pay. Date : 2021-03-30
DMF Number : 7033
Submission : 1987-06-18
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-08-21
Pay. Date : 2020-07-29
DMF Number : 34964
Submission : 2020-07-29
Status : Active
Type : II
NDC Package Code : 72166-005
Start Marketing Date : 2018-04-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33480
Submission : 2019-01-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-12-29
Pay. Date : 2018-10-11
DMF Number : 32136
Submission : 2018-02-09
Status : Active
Type : II
NDC Package Code : 76339-138
Start Marketing Date : 2019-09-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (4.999kg/4.999kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28840
Submission : 2015-12-03
Status : Active
Type : II
NDC Package Code : 64181-0088
Start Marketing Date : 1996-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-11-06
Pay. Date : 2018-09-28
DMF Number : 33126
Submission : 2018-09-30
Status : Active
Type : II
NDC Package Code : 66064-1023
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-24
Pay. Date : 2013-10-22
DMF Number : 23719
Submission : 2010-06-04
Status : Active
Type : II
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
About the Company : We are a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to ...
About the Company : Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of ...
About the Company : Founded more than 40 years ago, our purpose has always been to provide high-quality, affordable medicines to the people who need them. Based on the solid foundation we have built, ...
About the Company : Hunan Huateng Pharmaceutical Co., Ltd. is a research-based manufacturer and supplier of combinatorial building blocks, organics and fine chemicals, with 5000m2 laboratory and over ...
About the Company : Kalintis Healthcare is a vision with a drive to create a health-conscious Pharmaceuticals Company serving to bring Wellness to Humanity. We develop robust in-house technology by se...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
74
PharmaCompass offers a list of Benztropine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benztropine manufacturer or Benztropine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benztropine manufacturer or Benztropine supplier.
PharmaCompass also assists you with knowing the Benztropine API Price utilized in the formulation of products. Benztropine API Price is not always fixed or binding as the Benztropine Price is obtained through a variety of data sources. The Benztropine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MK 02 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MK 02, including repackagers and relabelers. The FDA regulates MK 02 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MK 02 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MK 02 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MK 02 supplier is an individual or a company that provides MK 02 active pharmaceutical ingredient (API) or MK 02 finished formulations upon request. The MK 02 suppliers may include MK 02 API manufacturers, exporters, distributors and traders.
click here to find a list of MK 02 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A MK 02 DMF (Drug Master File) is a document detailing the whole manufacturing process of MK 02 active pharmaceutical ingredient (API) in detail. Different forms of MK 02 DMFs exist exist since differing nations have different regulations, such as MK 02 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A MK 02 DMF submitted to regulatory agencies in the US is known as a USDMF. MK 02 USDMF includes data on MK 02's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MK 02 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of MK 02 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MK 02 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for MK 02 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture MK 02 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain MK 02 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MK 02 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of MK 02 suppliers with NDC on PharmaCompass.
MK 02 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of MK 02 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MK 02 GMP manufacturer or MK 02 GMP API supplier for your needs.
A MK 02 CoA (Certificate of Analysis) is a formal document that attests to MK 02's compliance with MK 02 specifications and serves as a tool for batch-level quality control.
MK 02 CoA mostly includes findings from lab analyses of a specific batch. For each MK 02 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
MK 02 may be tested according to a variety of international standards, such as European Pharmacopoeia (MK 02 EP), MK 02 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MK 02 USP).